Please use this identifier to cite or link to this item:
Scopus Web of Science® Altmetric
Type: Journal article
Title: New drugs for HDL-C disorders: the beginning
Author: Duong, M.
Nicholls, S.
Citation: Current Medicinal Chemistry, 2014; 21(25):2947-2951
Publisher: Bentham Science Publishers
Issue Date: 2014
ISSN: 0929-8673
Statement of
MyNgan Duong and Stephen J. Nicholls
Abstract: For more than 20 years there has been increasing interest in the development of novel therapies to raise levels of high-density lipoprotein cholesterol (HDL-C). However, well publicized failures of recent clinical trials of agents that raise HDL-C levels have stimulated considerable controversy with regard to the potential clinical utility of this therapeutic target. A number of classes of agents are currently under investigation with variable effects on HDL quantity and quality. These will be reviewed.
Keywords: Atherosclerosis; cardiovascular disease; HDL; lipids; risk factors
Rights: © 2016 Bentham Science Publishers
DOI: 10.2174/0929867321666140414104130
Appears in Collections:Aurora harvest 3
Medicine publications

Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.